Perspectives  ||| S:0 E:13 ||| NNP
on  ||| S:13 E:16 ||| IN
the  ||| S:16 E:20 ||| DT
crisis  ||| S:20 E:27 ||| NN
and  ||| S:27 E:31 ||| CC
challenge  ||| S:31 E:41 ||| NN
of  ||| S:41 E:44 ||| IN
cardiovascular  ||| S:44 E:59 ||| JJ
disease  ||| S:59 E:67 ||| NN
in  ||| S:67 E:70 ||| IN
the  ||| S:70 E:74 ||| DT
diverse  ||| S:74 E:82 ||| JJ
Asian  ||| S:82 E:88 ||| JJ
populations  ||| S:88 E:100 ||| NNS
of  ||| S:100 E:103 ||| IN
California  ||| S:103 E:114 ||| NNP
Recent  ||| S:114 E:121 ||| JJ
data  ||| S:121 E:126 ||| NNS
demonstrate  ||| S:126 E:138 ||| VBP
alarming  ||| S:138 E:147 ||| JJ
increases  ||| S:147 E:157 ||| NNS
in  ||| S:157 E:160 ||| IN
mortality  ||| S:160 E:170 ||| NN
from  ||| S:170 E:175 ||| IN
cardiovascular  ||| S:175 E:190 ||| JJ
disease  ||| S:190 E:198 ||| NN
and  ||| S:198 E:202 ||| CC
increase  ||| S:202 E:211 ||| NN
in  ||| S:211 E:214 ||| IN
risk  ||| S:214 E:219 ||| NN
factors  ||| S:219 E:227 ||| NNS
that  ||| S:227 E:232 ||| WDT
are  ||| S:232 E:236 ||| VBP
pushing  ||| S:236 E:244 ||| VBG
this  ||| S:244 E:249 ||| DT
disease  ||| S:249 E:257 ||| NN
to  ||| S:257 E:260 ||| TO
epidemic  ||| S:260 E:269 ||| VB
proportions  ||| S:269 E:281 ||| NNS
in  ||| S:281 E:284 ||| IN
Asians  ||| S:284 E:291 ||| NNPS
living  ||| S:291 E:298 ||| VBG
in  ||| S:298 E:301 ||| IN
the  ||| S:301 E:305 ||| DT
Bay  ||| S:305 E:309 ||| NNP
Area  ||| S:309 E:314 ||| NNP
of  ||| S:314 E:317 ||| IN
Northern  ||| S:317 E:326 ||| NNP
California ||| S:326 E:336 ||| NNP
.  ||| S:336 E:338 ||| .
Although  ||| S:338 E:347 ||| IN
genetics  ||| S:347 E:356 ||| NNS
may  ||| S:356 E:360 ||| MD
have  ||| S:360 E:365 ||| VB
an  ||| S:365 E:368 ||| DT
important  ||| S:368 E:378 ||| JJ
role ||| S:378 E:382 ||| NN
,  ||| S:382 E:384 ||| ,
environmental  ||| S:384 E:398 ||| JJ
factors  ||| S:398 E:406 ||| NNS
including  ||| S:406 E:416 ||| VBG
diet ||| S:416 E:420 ||| NN
,  ||| S:420 E:422 ||| ,
stress  ||| S:422 E:429 ||| NN
and  ||| S:429 E:433 ||| CC
lack  ||| S:433 E:438 ||| NN
of  ||| S:438 E:441 ||| IN
exercise  ||| S:441 E:450 ||| NN
are  ||| S:450 E:454 ||| VBP
contributing  ||| S:454 E:467 ||| VBG
to  ||| S:467 E:470 ||| TO
the  ||| S:470 E:474 ||| DT
incidence  ||| S:474 E:484 ||| NN
of  ||| S:484 E:487 ||| IN
hypertension ||| S:487 E:499 ||| NN
,  ||| S:499 E:501 ||| ,
diabetes  ||| S:501 E:510 ||| NN
and  ||| S:510 E:514 ||| CC
obesity  ||| S:514 E:522 ||| NN
in  ||| S:522 E:525 ||| IN
this  ||| S:525 E:530 ||| DT
population ||| S:530 E:540 ||| NN
.  ||| S:540 E:542 ||| .
Research  ||| S:542 E:551 ||| NN
at  ||| S:551 E:554 ||| IN
the  ||| S:554 E:558 ||| DT
San  ||| S:558 E:562 ||| NNP
Francisco  ||| S:562 E:572 ||| NNP
Heart  ||| S:572 E:578 ||| NNP
and  ||| S:578 E:582 ||| CC
Vascular  ||| S:582 E:591 ||| NNP
Institute  ||| S:591 E:601 ||| NNP
in  ||| S:601 E:604 ||| IN
Daly  ||| S:604 E:609 ||| NNP
City ||| S:609 E:613 ||| NNP
,  ||| S:613 E:615 ||| ,
California  ||| S:615 E:626 ||| NNP
shows  ||| S:626 E:632 ||| VBZ
that  ||| S:632 E:637 ||| IN
this  ||| S:637 E:642 ||| DT
trend  ||| S:642 E:648 ||| NN
is  ||| S:648 E:651 ||| VBZ
continuing ||| S:651 E:661 ||| VBG
,  ||| S:661 E:663 ||| ,
and  ||| S:663 E:667 ||| CC
combined  ||| S:667 E:676 ||| VBN
with  ||| S:676 E:681 ||| IN
a  ||| S:681 E:683 ||| DT
delay  ||| S:683 E:689 ||| NN
in  ||| S:689 E:692 ||| IN
seeking  ||| S:692 E:700 ||| VBG
treatment  ||| S:700 E:710 ||| NN
in  ||| S:710 E:713 ||| IN
this  ||| S:713 E:718 ||| DT
diverse  ||| S:718 E:726 ||| JJ
ethnic  ||| S:726 E:733 ||| JJ
group ||| S:733 E:738 ||| NN
,  ||| S:738 E:740 ||| ,
leads  ||| S:740 E:746 ||| VBZ
to  ||| S:746 E:749 ||| TO
poorer  ||| S:749 E:756 ||| JJR
outcomes  ||| S:756 E:765 ||| NNS
in  ||| S:765 E:768 ||| IN
revascularization  ||| S:768 E:786 ||| JJ
therapies  ||| S:786 E:796 ||| NNS
used  ||| S:796 E:801 ||| VBN
to  ||| S:801 E:804 ||| TO
treat  ||| S:804 E:810 ||| VB
these  ||| S:810 E:816 ||| DT
patients ||| S:816 E:824 ||| NNS
.  ||| S:824 E:826 ||| .
More  ||| S:826 E:831 ||| RBR
intensive  ||| S:831 E:841 ||| JJ
community  ||| S:841 E:851 ||| NN
education  ||| S:851 E:861 ||| NN
that  ||| S:861 E:866 ||| WDT
includes  ||| S:866 E:875 ||| VBZ
patients  ||| S:875 E:884 ||| NNS
and  ||| S:884 E:888 ||| CC
his ||| S:888 E:891 ||| PRP$
/ ||| S:891 E:892 ||| NN
her  ||| S:892 E:896 ||| PRP$
family  ||| S:896 E:903 ||| NN
and  ||| S:903 E:907 ||| CC
more  ||| S:907 E:912 ||| RBR
aggressive  ||| S:912 E:923 ||| JJ
preventive  ||| S:923 E:934 ||| JJ
treatment  ||| S:934 E:944 ||| NN
programs  ||| S:944 E:953 ||| NNS
are  ||| S:953 E:957 ||| VBP
needed  ||| S:957 E:964 ||| VBN
to  ||| S:964 E:967 ||| TO
slow  ||| S:967 E:972 ||| VB
the  ||| S:972 E:976 ||| DT
progress  ||| S:976 E:985 ||| NN
of  ||| S:985 E:988 ||| IN
this  ||| S:988 E:993 ||| DT
growing  ||| S:993 E:1001 ||| VBG
health  ||| S:1001 E:1008 ||| NN
problem ||| S:1008 E:1015 ||| NN
.  ||| S:1015 E:1017 ||| .
